These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 20158950)

  • 21. AroD deletion attenuates Shigella flexneri strain 2457T and makes it a safe and efficacious oral vaccine in monkeys.
    Kärnell A; Cam PD; Verma N; Lindberg AA
    Vaccine; 1993; 11(8):830-6. PubMed ID: 8356844
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preparation, characterization, and immunogenicity of conjugates composed of the O-specific polysaccharide of Shigella dysenteriae type 1 (Shiga's bacillus) bound to tetanus toxoid.
    Chu CY; Liu BK; Watson D; Szu SS; Bryla D; Shiloach J; Schneerson R; Robbins JB
    Infect Immun; 1991 Dec; 59(12):4450-8. PubMed ID: 1937803
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection of non-culturable Shigella dysenteriae 1 from artificially contaminated volunteers' fingers using fluorescent antibody and PCR techniques.
    Islam MS; Hossain MZ; Khan SI; Felsenstein A; Sack RB; Albert MJ
    J Diarrhoeal Dis Res; 1997 Jun; 15(2):65-70. PubMed ID: 9360343
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Shigellosis in cynomolgus monkeys (Macaca irus). VII. Experimental production of dysentery with a relatively small dose of Shigella flexneri 2a in ascorbic acid deficient monkeys.
    Honjo S; Takasaka M; Fujiwara T; Imaizumi K; Ogawa H
    Jpn J Med Sci Biol; 1969 Jun; 22(3):149-62. PubMed ID: 4981384
    [No Abstract]   [Full Text] [Related]  

  • 25. Shigellosis.
    Niyogi SK
    J Microbiol; 2005 Apr; 43(2):133-43. PubMed ID: 15880088
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oral immunization of Escherichia albertii strain DM104 induces protective immunity against Shigella dysenteriae type 4 in mouse model.
    Chowdhury FM; Ahsan CR; Birkeland NK
    Acta Microbiol Immunol Hung; 2021 Jul; ():. PubMed ID: 34292874
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detection of Shigella dysenteriae type 1 and Shigella flexneri in feces by immunomagnetic isolation and polymerase chain reaction.
    Islam D; Lindberg AA
    J Clin Microbiol; 1992 Nov; 30(11):2801-6. PubMed ID: 1452650
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Construction and characterization of a live attenuated vaccine candidate against Shigella dysenteriae type 1.
    Klee SR; Tzschaschel BD; Fält I; Kärnell A; Lindberg AA; Timmis KN; Guzmán CA
    Infect Immun; 1997 Jun; 65(6):2112-8. PubMed ID: 9169740
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Production of IFN-gamma and IL-10 to Shigella invasins by mononuclear cells from volunteers orally inoculated with a Shiga toxin-deleted Shigella dysenteriae type 1 strain.
    Samandari T; Kotloff KL; Losonsky GA; Picking WD; Sansonetti PJ; Levine MM; Sztein MB
    J Immunol; 2000 Feb; 164(4):2221-32. PubMed ID: 10657678
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Shigellosis due to Shigella dysenteriae. 1. Relative importance of mucosal invasion versus toxin production in pathogenesis.
    Gemski P; Takeuchi A; Washington O; Formal SB
    J Infect Dis; 1972 Nov; 126(5):523-30. PubMed ID: 4197755
    [No Abstract]   [Full Text] [Related]  

  • 31. Low risk of hemolytic uremic syndrome after early effective antimicrobial therapy for Shigella dysenteriae type 1 infection in Bangladesh.
    Bennish ML; Khan WA; Begum M; Bridges EA; Ahmed S; Saha D; Salam MA; Acheson D; Ryan ET
    Clin Infect Dis; 2006 Feb; 42(3):356-62. PubMed ID: 16392080
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Introduction and spread of multi-resistant Shigella dysenteriae I in Thailand.
    Taylor DN; Bodhidatta L; Brown JE; Echeverria P; Kunanusont C; Naigowit P; Hanchalay S; Chatkaeomorakot A; Lindberg AA
    Am J Trop Med Hyg; 1989 Jan; 40(1):77-85. PubMed ID: 2644859
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fecal excretion of leukotriene C4 during human disease due to Shigella dysenteriae.
    Cruz JR; Cano F; Razin E; Acheson DW; Keusch GT
    J Pediatr Gastroenterol Nutr; 1995 Feb; 20(2):179-83. PubMed ID: 7714683
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quantitative assessment of IgG and IgA subclass producing cells in rectal mucosa during shigellosis.
    Islam D; Veress B; Bardhan PK; Lindberg AA; Christensson B
    J Clin Pathol; 1997 Jun; 50(6):513-20. PubMed ID: 9378821
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Protective role of lactobacilli in Shigella dysenteriae 1-induced diarrhea in rats.
    Moorthy G; Murali MR; Devaraj SN
    Nutrition; 2007 May; 23(5):424-33. PubMed ID: 17483010
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunogenicity of multivalent Shigella-ETEC candidate vaccine strains in a guinea pig model.
    Barry EM; Wang J; Wu T; Davis T; Levine MM
    Vaccine; 2006 May; 24(18):3727-34. PubMed ID: 16169130
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Survival of Shigella dysenteriae type 1 on fomites.
    Islam MS; Hossain MA; Khan SI; Khan MN; Sack RB; Albert MJ; Huq A; Colwell RR
    J Health Popul Nutr; 2001 Sep; 19(3):177-82. PubMed ID: 11761771
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification difficulties with Shigella dysenteriae, serotype 1.
    Adler DL; King BM
    Am J Clin Pathol; 1967 Feb; 47(2):186-9. PubMed ID: 4912704
    [No Abstract]   [Full Text] [Related]  

  • 39. Immunoglobulin subclass distribution and dynamics of Shigella-specific antibody responses in serum and stool samples in shigellosis.
    Islam D; Wretlind B; Ryd M; Lindberg AA; Christensson B
    Infect Immun; 1995 May; 63(5):2054-61. PubMed ID: 7729920
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis, characterization, and clinical evaluation of conjugate vaccines composed of the O-specific polysaccharides of Shigella dysenteriae type 1, Shigella flexneri type 2a, and Shigella sonnei (Plesiomonas shigelloides) bound to bacterial toxoids.
    Taylor DN; Trofa AC; Sadoff J; Chu C; Bryla D; Shiloach J; Cohen D; Ashkenazi S; Lerman Y; Egan W
    Infect Immun; 1993 Sep; 61(9):3678-87. PubMed ID: 8359890
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.